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ABSTRACT
Use of tobacco has remained one of the most lethal pastimes within the United States. With the
creation of new products, like electronic cigarettes (e-cigarettes), more and more individuals
have begun to engage in this activity. In 2019, an epidemic surrounding the use of e-cigarettes
emerged causing a multitude of users to suffer harmful respiratory illnesses. These events
triggered the need for further investigation not only into the research used to analyze e-cigarettes,
but also the regulation process used to validate them. E-cigarettes, like their predecessor
traditional cigarettes, are regulated by the Center for Tobacco Products (CTP) within the United
States Food and Drug Administration (FDA). Through premarket tobacco product applications
(PMTA), the CTP determines whether tobacco products are safe for public use. This thesis was
used to investigate whether the current regulatory process is able to effectively analyze all of the
risks and health implications associated with the use of e-cigarettes. After reviewing research
from literature to define the current state of knowledge surrounding the health impacts of ecigarettes, an applied case study was conducted to determine whether the research in the PMTA
was sufficient in assessing the safety of these devices. The findings of this research reveal that
although the PMTA included some of the important research areas found in the literature review,
its analysis was limited due to the continuous reliance on the comparison of e-cigarettes and
traditional cigarettes to validate the argument of safety.
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CHAPTER 1: INTRODUCTION
Within the United States, the use of tobacco remains one of the most hazardous
recreational activities, resulting in over 480,000 preventable deaths per year (Centers for Disease
Control and Prevention [CDC], n.d.a). Since their creation in the 19th century, traditional
cigarettes have steadily increased in popularity throughout society (“History of Tobacco”, n.d.).
Although they remain popular, traditional cigarettes are only one type of tobacco product. Other
tobacco products on the market include: cigars, snuff, chewing tobacco, hookah, and most
recently electronic cigarettes (e-cigarettes). The creation of these devices classified as ecigarettes or electronic nicotine delivery system (ENDS) has introduced a rapidly expanding
market, especially in the United States. The users of e-cigarette devices are comprised of not
only adults, but also children. In 2018, the United States Food and Drug Administration (FDA)
noted that 3.62 million middle and high school students are e-cigarettes users and in 2019, this
same number escalated to 5 million. (U.S. Food and Drug Administration [FDA], n.d.e, n.d.d).
Although e-cigarettes have been approved by the Center for Tobacco Products (CTP)
within the U.S. Food and Drug Administration (FDA), emerging evidence has revealed that these
devices are potentially more hazardous than previously publicized (Knowles and Sun, 2019).
Little research has been done to accurately assess all of the health effects, both short- and longterm, of these devices (Sharpless, 2019.) Specifically, no research has been done to evaluate the
potential negative health effects caused by the ingredients in e-cigarette liquids. For example,
although deemed safe by the FDA, propylene glycol, a compound commonly used in e-cigarette
liquids (e-liquids), was only researched for use in topical, oral, and injectable consumer products
(Cobb and Abrams, 2011). Since the e-liquids change from liquid to vapor, inhaling propylene
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glycol could stimulate alternative effects from those previously seen in the research of approved
consumer products.
There is a vast amount of variability amongst types of e-cigarettes. Currently, e-cigarettes
are classified by their product design; some resemble USB flash drives, while others
resemble pens. Diversity of design, however, is not the only variable factor within these devices.
There are a multitude of ingredients that make up the e-liquids used in e-cigarettes. In 2014,
there were not only 466 different brands of e-cigarettes, but also 7764 distinctive flavors being
sold online (Zhu et al., 2014). The addition of flavors creates vast differences, particularly, in the
concentration of nicotine being used in the formulas. Although the ability to modify and
customize e-cigarettes is commonly used as a marketing ploy by companies to increase the sale
of their products (Zhu et al., 2014), the diversity of e-cigarettes also warrants questions
surrounding both the risks to e-cigarette users and the efficacy of the regulation process in
analyzing these devices. These modifications could potentially impact both the function and the
use of the device, which could alter how they should be analyzed.
Recently, there has been an abundance of events surrounding the development of
respiratory illnesses in e-cigarettes users. Many individuals have succumbed to acute respiratory
distress syndrome, a life-threatening condition caused by the accumulation of fluid in the lungs,
which obstructs the circulation of oxygen in the bloodstream (Knowles and Sun, 2019),
preventing the
body from functioning properly. The latest outbreak information indicates that there has been
almost 1479 e-cigarette associated respiratory injury cases and 33 confirmed deaths (CDC,
n.d.d).
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Due to the rising number of cases, state officials have taken legislation of e-cigarettes
into their own hands, allowing them to decrease the regulatory void created by the indolence of
the federal government (“Outbreak of Lung Injury”, n.d.). Michigan, for instance, was the first of
many states to create e-cigarette legislation. The state government limited the sale of e-cigarettes
by placing an emergency ban on all flavors other than tobacco. In February of 2020, the resident
officially enacted a federal ban on the flavored e-cigarette products.
The overall goal of this thesis is to determine whether the regulatory process for ecigarettes allows for effective review of the safety of e-cigarettes. The thesis will focus on one of
the only Premarket Tobacco Product Applications available to the public. By evaluating the
content in the PTMA, I will be able to examine what characteristics are included when assessing
the harmfulness of e-cigarettes and determine whether the evaluation of these characteristics is
sufficient by comparing them research found within the broader academic literature. I will also
identify any areas were overlooked or ignored within the substantial review process.
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CHAPTER 2: RESEARCH QUESTIONS
There is a lot of variation between cigarettes not only in their design, but also in their
auxiliary components, like e-liquids. Although substantial equivalence can be used to show that a
device is similar to an already marketed device, how do we know whether the disparity between
the devices does not have hazardous health consequences? Of the 302 applications submitted
during the 2019 fiscal year, 296 applications were submitted through the substantial equivalence
pathway (FDA, n.d.a). If there is a comparison being made, between electronic cigarettes or
even traditional cigarettes, then what are areas the of research being used to examine their
similarities?
The research of this thesis focuses on the regulation of e-cigarettes. In 2019, there was
not only a large growth in the number of youth users, but also a large number of individuals who
became impaired, even hospitalized, due to their use of these products. Through regulation, these
devices were able to receive a marketing order, which means that they were proposed to be safe
for the public. In order to create a solution, we have to determine where the problem occurs.
Thus, the process of regulating these devices needs to be analyzed in order to determine what
factors inhibited the regulation process from uncovering the health problems associated with the
device. The research within this thesis surrounds two large questions:
-

Is the evidence provided in PTMAs adequate to claim substantial equivalence?

-

Has the Premarket Tobacco Product Applications (PTMA) been effective in the
regulation of e-cigarettes?

The first question looks at the information that companies provide within their PMTA. I
will look at what scientific research companies supply for the Substantive Review phase of the
PMTA process. This will allow me to examine the findings of their research, assess the quality of
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research, and compare their findings with the literature. From this information, I cannot only
determine what evidence is provided, but also whether it is substantial in the analysis of ecigarette devices.
The second question surrounds the one of the main functions of the Family Smoking
Prevention and Tobacco Control Act (FSPTCA), which is to create a process that effectively
regulates e-cigarettes, a type of tobacco product. To determine the effectiveness of the process,
we have to determine whether the research included in the PMTA incorporate all of the areas
important in analyzing the devices. Important areas will be determined decided by the areas that
are identified as important in academic literature.

Lara 7

CHAPTER 3: BACKGROUND
Beginning in the 1960s, there has been a multitude of policy measures that have impacted
both the advertisement and use of tobacco products. From the Federal Cigarette Labeling and
Advertising Act of 1965 to the Public Health Cigarette Smoking Act of 1969, tobacco products
have been a controversial topic within legislature (Centers for Disease Control and Prevention,
n.d.c). In 2009, President Barack Obama gave the FDA the ability to regulate tobacco products
through the creation of the Family Smoking Prevention and Tobacco Control Act (FSPTCA)
under the Food, Drug, and Cosmetic Act. In addition to producing standards for tobacco
products, the FDA can require companies to disclose both the contents of their products and the
research used to evaluate their health effects (Public Health Center, n.d.).
Before being placed on the market, “new tobacco products” have to receive a tobacco
product marketing order from the FDA. “New tobacco products” are defined as tobacco products
that were not commercially marketed before February 15, 2007. In order to receive approval,
companies can go through three different pathways: submitting of a premarket tobacco product
applications (PMTA), demonstrating substantial equivalence, or requesting an exemption from
substantial equivalence. These applications allow the FDA to assess the benefits and risks of the
product on public, both users and non-users (FDA, n.d.c). Therefore, all tobacco products,
including e-cigarettes must go through this regulatory process, as shown in Figure 1.

Presubmission
Meeting

Acceptance
Review

Filing
Review

Substantive
Review

Action

Figure 1: The six steps of the FDA regulatory process for PMTA (FDA, n.d.c).

Postmarket
Reporting
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The process begins with a Presubmission Meeting, an optional meeting between the
company and the Center for Tobacco Products (CTP) where the company can receive guidance
and assistance regarding their plans prior to submitting the PMTA. After the submission of the
PMTA, the CTP conducts an Acceptance Review to confirm whether the product falls under its
jurisdiction. Following the Acceptance Review, the Filing Review phase is used to verify that the
PMTA includes all the necessary items. This thesis is focused on the step that succeeds the Filing
Review, the Substantive Review. Substantive Review determines whether companies will
receive a marketing order letter for their device which is officially granted in the Action phase of
the process. Substantive Review is the phase where the CTP examines the scientific research that
was submitted within the PMTA and provides recommendations. Within this step, the scientific
research is used to provide evidence showing the health-related effects related to the tobacco
product, allowing the CTP to assess its safety. Postmarket Reporting is the last phase of the
process. After receiving a marketing letter, the FDA requires companies to keep information on
the product.
E-cigarettes are battery operated devices classified by their ability to heat liquids into
aerosols, a mixture of liquid or solid particles in a gas. Initially, in 2011, the FDA wanted to
regulate electronic cigarettes as drug delivery devices. However, since there were no therapeutic
claims surrounding the devices, the courts denied their request and required e-cigarettes to be
regulated as tobacco products citing the FSPTCA as the reason for the ruling (Cobb and Abrams,
2011). The first e-cigarette was created in the 1960s, when Hebert A. Gilbert submitted a patent
for a ‘smokeless nontobacco cigarette’, an alternative to smoking cigarettes (U.S. Department of
Health and Human Services et al., 2016, p.10). E-cigarettes have four common pieces within
their design: a power source, a heating element, a pressure switch, and a battery. First generation
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e-cigarettes are classified by their likeness to traditional cigarettes. These devices resemble both
the look and the feel of traditional cigarettes, becoming an alternative for smoking. Second
generation e-cigarettes are devices characterized by two elements, an atomizer or thin battery,
and a clearomizer, a clear cartridge that holds the e-liquids (“E-cigarette Devices, Uses”, 2018).
Unlike the first two generations, third generation e-cigarettes bear no resemblance to traditional
cigarettes. They are classified by the ability of their parts to be customizable, replaceable, and
refillable.

Figure 2: The image above illustrates the differences between the various generation of ecigarettes (Truth Initiative, 2019).
The main difference between e-cigarettes and traditional cigarettes is the absence of
tobacco in e-liquids. Unlike traditional cigarettes, e-cigarettes contain nicotine, an addictive
substance found in tobacco. Products like e-cigarettes and other non-smokable products are
perceived to be less harmful by the public not only because they have lower concentrations of
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harmful chemicals, but also because they do not rely on combustion (Pepper et al., 2014).
Although the ingredients within the e-liquid, for instance nicotine, are less concentrated, they
still have deleterious effects. Diseases associated with smoking traditional cigarettes, like lung
cancer and emphysema, develop after years of constant smoking. Recent events, however, have
shown that damage to the lungs can occur in less than a year (“Is Vaping Safer than”, 2019).
Table 1 lists some of the ingredients mentioned by the American Lung Association that are
typically found in e-cigarettes.

Table 1: List of Ingredients in e-cigarettes compiled from American Lung Association.
Ingredients

Uses

Propylene glycol

Common food additive. Used to make
antifreeze and paint solvent.

Acrolein

Herbicide used to kill weeds

Diacetyl

Chemical linked to bronchiolitis obliterans
(popcorn lung)

Benzene

Volatile compound found in car exhaust

Cadmium

Toxic metal linked with breathing problems and
disease
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CHAPTER 4: METHODS
The methods of the thesis can be separated into two parts, the methods for the literature
review and the methods used to find the premarket tobacco product applications (PMTA).

Literature Review
The information gathered within this literature review is separated into three different
categories: various generations of e-cigarettes, the comparison of e-cigarettes to traditional
cigarettes, and the comparison of the materials in both e-liquids and aerosols. To find materials,
two different databases, google scholar and RIT library were utilized. The search terms include:
“health e-cigarettes”, “chemicals in e-cigarettes”, “chemical in e-cigarettes”, “e-cigarette
flavor compounds”, “first generation e-cigarettes”, “second generation e-cigarettes”, “third
generation e-cigarettes” and “traditional and e-cigarettes”. Through the multiple searches,
seventy papers were found.
Since the material within this literature review was being used to identify important
research, it was imperative that they were experimental research that looked at the health effects
associated with e-cigarettes. Many of the documents that came back were patents of e-cigarettes
and news articles of current events. Patents were excluded from this review because although
they illustrate the versatility in design, patents are unable to show whether the design of ecigarettes impacts the health of its users. News articles provide good background information,
but they do not provide data in relation to the scientific analysis of e-cigarettes. They can account
for what injuries are frequent amongst users, but they cannot show the relationship between what
is causing these health-related issues; thus, they were also excluded from this literature review.
Other research that was excluded includes research that focused only on defining the differences
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without discussing the impact on health. The absence of health impact would not allow this paper
to gather enough information about the implications that versatility could potentially have on
health. After refining the search criteria, twenty-seven papers were selected to provide data that
would allow me to find ideas that were prevalent amongst different areas of research.

Applied Case Study
Locating the premarket tobacco product applications was a difficult task. The Food and
Drug Administration, which is made up of several centers, had a lot of information that on its
website. I had to use the FDA search for the information that I was hoping to acquire. After
locating the applications with the ‘premarket tobacco application’ search term, I was able to
examine applications using the seventh link titled, “Premarket Tobacco Product Marketing
Order” (FDA, n.d.b). The page listed marketing orders for PMTAs from two separate years,
2015 or 2019. Within these two years, there was a total of four PMTAs e-cigarette devices,
however, they were all under the 2019 fiscal year and submitted by one company, Phillip Morris
S.A. (FDA, n.d.b).
Since the analysis of this thesis relied heavily on the details of the PMTA, the acquisition
of these documents was a sizable limitation. I did not want to rely solely on a few PMTAs,
especially since they were all submitted by a single company. In order to rectify the situation, I
attempted to obtain more applications. Initially, I reached out to several individuals and
departments associated with the FDA through email and phone to initiate correspondence about
finding additional PMTAs, however, I was not able to find more information through this route.
The information provided by these sources referred me back to information I already acquired
when searching the FDA website. In addition to this, through the help of my advisor, I was able
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to use a resource called MuckRock. Through the Freedom of Information Act, MuckRock is able
to assist individuals in gathering government documents. Through this platform, I requested to
see e-cigarette PMTAs from 2018, however this request was denied. In March, I received a
response, located in appendix 1, which noted that the existence of PMTAs could neither
confirmed nor denied, referencing “Extemption 4 of the FOIA and 21 CFR 20.61 (b)(c)”
(appendix 1).
Since I was unable to acquire additional PMTAs, I was restricted to the four applications
submitted by Phillip Morris S.A that I located on the FDA website. These four applications were
based on the flavor of the heatsticks (3) that were used in the devices and the actual system.
Under closer examination, I found that there were no major differences between them and that
they all included similar information and research. Thus, I chose to focus on one of the
applications for this thesis. The specific application analyzed was the first of the four
applications located on the ‘Premarket Tobacco Product Marketing Order’ page under the
PMTAs for the 2019 fiscal year, titled ‘PM0000424’, associated with the Marlboro Menthol
Heatsticks.
The PMTA was organized in five different sections: Executive Summary, Review of
PMTA, Product Labeling, Consumer Comprehension, & Marketing Plan, and Conclusions &
Recommendations (FDA, 2019, p. 6-7). The second section, Review of PMTA, contained three
subsections that focused on the experimental research done to analyze the device. The three subsections were: Toxicological Risk Assessment, Behavioral & Clinical Pharmacological
Assessment, and Individual Health Impact. Although these sections contained information about
the experiments, they mostly were a summary of the experiments and commentary from
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individuals from the CTP. For example, most of the quantitive data was excluded from the
PMTA.
To develop a clearer understanding of the evidence, I attempted to find the
documentation of the actual experiments. Three experiments were found by using the
experimental numbers that were referenced within the PMTA. The first experiment, which
focused on smoking topography was referenced as ‘ZRHM-REXA-08’. The next experiment,
referenced by ‘ZRHM-PK-06-US’, was focused on pharmacokinetics. The final experiment
number, ‘RLS-ZRH-2015-249, included details about all of the in vivo experiments that focused
on aerosol toxicity.
To find the detailed information about the experiments executed in the PMTA, a google
search was conducted using the experimental number with the addition of the search term
‘pmiscience’. For example, for the data for the smoking topography was found using the search
term ‘ZRHM-REXA-08 pmiscience’. There were some redactions within PMI science documents,
however, they did not take away from the data or the findings of the experiments.
Analysis
Gathering and organizing the scientific research collected was an immense portion of this
thesis. The first analysis was conducted during the literature review, resulting in the definition of
the important research areas for e-cigarettes. These areas helped to organize the research of the
PMTA into three sections: Smoking Topography, the Pharmacological Assessment of Nicotine,
and Aerosol Toxicity. From the experimental research of the experiments within the PMTA,
each experiment was detailed to develop of an understanding of what was done and to learn the
findings. In addition to defining the research areas, the research from the literature review was
used for a comparison. The findings from those papers were compared to the experiments
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conducted within the PMTA. In addition to the comparison between the research, the findings
were organized by their potential for health impact by denoting them as ‘low’, ‘medium’, and
‘high’. This was used to help categorize the information establishing a correlation with
importance. High health impact implies that it there is a high importance when assessing the
health effects during the analysis of these devices. The results of the research comparisons thesis
allowed for evaluation into the effectiveness of e-cigarette regulation.
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CHAPTER 5: FINDINGS
Findings can be broken in three sections: research areas within literature important in
evaluating e-cigarettes, experimental areas included within the premarket tobacco product
application (PMTA), and the assessment of research quality within the Pre-market tobacco
application. In addition to showing the importance of different e-cigarette areas that are
researched, I will also make several comparisons between what is shown in literature, what is
provided in the PMTA, ultimately, determining whether the evidence provided in the PMTA is
substantial enough to be considered safe for consumers.
I will review my findings, starting with a review of areas and ideas that are critical when
analyzing the health effects of e-cigarettes. After defining these research areas, I will use them to
organize the experiments of the PMTA and see what evidence, if any, was provided. Following
the discussion surrounding the findings of each experiments, I will then compare the findings of
research used in the literature review to the findings of the PMTA. Finally, I will assess the
quality of data included in the PMTA.
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CHAPTER 5A: AREAS THAT IMPACT SMOKING (LITERATURE REVIEW)
Within the literature, research areas are able to provide evidence about what should be
considered when evaluating electronic cigarettes. In order to be considered safe and receive a
marketing order, tobacco products, like e-cigarettes, have to be tested to show the effects
associated with their usage. Both harmless and hazardous effects should be considered because
they play a role in the assessment of risks that consumers could potentially encounter. When
there is consistency between findings of research, it allows the importance of that subject area to
be emphasized. For instance, if the majority of research made claims that smoking behavior is
different in e-cigarettes, then the research within the PMTA should include research that
examines smoking behavior.
Findings do not always agree between research. This does not mean, however, that these
research areas are insignificant. Contrasts between findings in research show not only
inconsistencies between research, but also the need for further research in these areas. These
areas are also important in showing the risks of these e-cigarettes. Including these research areas
would be valuable addition to the regulatory process so that it could ensure that its review of
these devices is truly comprehensive.
Within the three categories below, a variety of research was used to examine the different
ideas and whether they were consistent. The three main focuses of the papers are the comparison
of the various generations of e-cigarettes, the comparison of e-cigarettes to traditional cigarettes,
and the comparison of the materials in both e-liquids and aerosols. These comparisons help to
identify areas that are necessary in assessing the harmfulness of the e-cigarettes.
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Electronic versus Traditional Cigarettes
Electronic and traditional cigarettes differ, especially in their usage. Eight papers were
used to develop the comparisons of this section. The papers within this section are limited. Four
of the papers only look at the short-term effects cause by the usage of e-cigarettes. Although the
other papers were not classified as having a short-term evaluation of health effects, their time
periods of evaluation were still short in comparison to the period it takes for noticing a different
in health effects. The longest evaluation time within this section which occurred in the study
conducted by Harrington, Cheong, Hendricks, and Kohler (2015) was 6 months. The most
common idea throughout these papers was a difference between the usage of e-cigarettes
compared to traditional cigarettes. In one study, researchers found that the participants
significantly increase the average time they puffed on e-cigarettes (Ceriana et al., 2015). Another
study also showed that although e-cigarettes deliver less nicotine to their users, the devices were
smoked more intensely than traditional cigarettes (Norton et al., 2014). After finishing, these
participants were also less satisfied.

Table 2: Ideas in Literature about Electronic and Traditional Cigarettes
Short Term
Evaluation of
Health E-ffects (<
1hr)

E-cigarettes induced
adverse effects

Difference between the
usage of e-cigarettes and
traditional Cigarettes

X

X

(Pepper et al., 2014)
(Ferrari et al., 2015)

X

(Vargas Trassierra et al., 2014)

X

(Papoušek et al., 2014)

X

X

(Lee et al., 2015)

X

X

(Harrington et al., 2015).

X

X
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(Farsalinos et al., 2017)
(Norton et al. , 2014)

X

X

X

X

X

Generations of E-Cigarettes
The papers within this section have two major ideas. E-cigarette users have preference
over the design of the e-cigarettes. E-cigarettes also have a difference in the delivery of nicotine,
which is dependent on the design. Research conducted in one of the papers found that third
generation e-cigarette users consume twice the amount of e-liquid compared to second
generation e-cigarette devices (Dawkins et al., 2014).

Table 3: Ideas in Literature in relation to Generation of E-cigarettes

(Rüther, et al., 2017)

Differences in the
delivery of
Nicotine
X

Short term
Evaluation of
Health Effects
X

User preference
differs with
design
X

Promotion of
Smoking
Cessation
X

(Dawkins et al., 2014)

X

X

X

X

(Chen, Zhuang, & Zhu, 2016)

X

(Lechner et al., 2015)

X

X

(Wagener et al., 2016)

X

X

(Farsalinos et al., 2015).

X

X

X

X

E-liquids and Aerosols
The research in this category differed by the variables researchers chose to measure.
Some looked at the particles in the aerosol, while others looked at the chemicals in the user’s
body. Two major findings within this section were that e-liquids alter the behavior of the smoker
and that the design of the device impacts the aerosols. For the first finding, seven papers
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illustrated how the behavior of the smoker was altered by the e-liquid. For example, in one study,
higher levels of carbonyls were related to intensive puffing. This demonstrated that individuals
using e-liquids of lower nicotine concentration puff longer to increase their exposure of these
nicotine (Corcoran et al., 2017). The second finding illustrated how design of the e-cigarettes
impacts the aerosol of e-cigarettes. In a study, researchers found higher concentrations of metals
in the e-liquid within different areas of the e-cigarette devices (Olmedo et al., 2018). The tank
and the aerosol had the highest level of metal concentrations, indicating that e-liquid
contamination is occurring throughout the process of using e-cigarettes.

Table 4: Ideas in Literature about E-liquids and Aerosols
E-liquids
can alter the
behavior of
the smoker
(Corcoran et al., 2017)

X

(Pourchez et al., 2018)

X

The level of substances
(metal, compounds,
and chemicals) in a
smoker’s system
increases

Negative
health
effects due
to the
e-liquid

Design of ecigarettes can
impact the aerosol
of the e-cigarettes

X

(St. Helen, 2018)

X

(Strongin, 2019)

X

X

(Kaur et al., 2018)

X

X

(Erythropel et al., 2018)

X

X

(Korzun et al., 2018)

X

(Klager et al. 2017)

X

(Dawkins et al., 2016)

X

(Dawkins & Corcoran,
2013)
(Papoušek, 2014)

X

(St. Helen, 2017)

X

(Olmedo et al., 2018)

X
X

X
X

X
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Overall
The papers gathered for this literature review provide insight into how the different
components of e-cigarettes affect their usage. Compared to traditional cigarettes, e-cigarettes are
used differently, which can be illustrated through the differences in the smoking behavior of the
users. Also, the creation of e-cigarettes, initially, was to provide aid in smoking cessation,
however, there are contradictions in the findings provided by the literature. When comparing
traditional cigarettes to e-cigarettes, Harrington et al. (2015) found that while e-cigarettes
decrease the frequency of smoking, they are not effective in promoting smoking cessation. This
finding differs from the research of Chen et al. (2016) where they found that second generation
devices promote both smoking cessation and satisfaction.
E-cigarettes also differ from traditional cigarettes due to their ingredients. Although there
are lower concentrations of harmful ingredients within e-cigarettes, it should not discount the
fact that they are still harmful. Allen et al. (2017) found that all of the e-cigarettes contained
chemicals that were considered dangerous by the FDA or Federal Emergency Management
Agency (FEMA). Most of the research conducted illustrate that traditional cigarettes have higher
toxic ingredients; however, this should not be the only benchmark to assess the healthiness of ecigarettes. The comparison only shows that e-cigarettes are better than traditional cigarettes, not
that they are harmless. Also, other considerations have to be made when assessing the harm of ecigarettes. There is an abundance of chemical reactions undergone throughout the vaping
process. For example, Erythopel et al. (2018) found that the conversion of aldehydes, a highly
reactive functional group, to acetals initiate the activation of irritant receptors within cells.
Therefore, the contents of the aerosols become an important indicator of exposure to harmful
materials.
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Most of the papers, regardless of the subject area, focused on the topography, or smoking
behavior of the users. Research by Dawkins et al. (2017) and Lee, Gawron, and Goniewicz
(2015) have different objectives, however, they were both conducted similarly utilizing patient
studies to collect user data. From the data, they were able to compile measurements regarding the
number of puffs, the duration of the puff, and the satisfaction of the user. Another common
finding between the research is the measurement of nicotine levels, which could be collected
from either the blood stream or aerosol of the users. Corcoran et al. (2016) measure nicotine
levels within the bloodstream while Farsalinos et al. (2017) measure nicotine levels within
aerosols. The final idea prevalent in the research is the ingredients within these e-cigarettes,
which can be examined through the e-liquids or the aerosols created by the device. From this
information, several areas appear significant when evaluating e-cigarettes: Smoking Topography
& Behavior, Assessment of Nicotine, and Aerosol Toxicity.
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CHAPTER 5B: CONTENTS OF PMTA
The Premarket Tobacco Product Application (PMTA) is broken into five distinct
sections: Executive Summary, Review of the PMTA, Product Labeling, Consumer
Comprehension, & Marketing Plan, and Conclusions & Recommendations. Specifically, Review
of the PMTA contains multiple subsections selected by the Center for Tobacco Products as areas
necessary for the evaluation of the electronic cigarette device created by the Phillip Morris S.A.
These research areas include but are not limited to behavior clinical pharmacology, chemistry,
environmental science, epidemiology, and toxicology. This section is used to examine the
research Phillip Morris included in the PMTA. Particularly, experiments categorized under that
areas from literature review that were deemed important.

Smoking Topography
Smoking topography describes the behavioral patterns of a smoker. It encompasses
elements such as the number and length of individual puffs a person takes while smoking
(Robinson et al., 2018). Through behavioral analyses, topography can illustrate the difference in
smoking regimens between different types of smokers and even the selection of settings on a
smoking machine used by researchers to replicate human smoking behavior.
Within the PMTA, Phillip Morris S.A. conducted four studies looking at the behavior of
individuals in the United States(1), Europe(1), and Japan(2). Within the United States, the study
observed 160 participants over a 91-day period, including 5 days within a confined setting and
86 days within an ambulatory setting. Participants consisted of healthy individuals who were at
least 22 years and older and smoked at least 10 menthol cigarettes per day (Lewis and Farmer
2016). There were three different groups within the study:
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-

Experimental group: Individuals who used the THS 2.2 Menthol device ad libitum for
5 days in the confined environment and 86 days in an ambulatory environment

-

Active comparator group: Individuals who used their own preferred brand of
traditional menthol cigarettes ad libitum for 5 days in the confined environment and
for 86 days in their ambulatory environment.

-

Sham Comparator group: Individuals who abstained from smoking for 5 days in a
confinement environment and 86 days in an ambulatory environment

For evaluation of the Phillip Morris S.A product, participants were given a self-report
questionnaire called the Modified Cigarette Evaluation Questionnaire. From this survey,
researchers were able to compare the craving reduction, enjoyment of respiratory tract sensation,
and smoking satisfaction between the experimental group and the active comparator group.
Researchers found that every category was lower for the experimental group, the individuals
using the Phillip Morris S.A. device. Table 5 illustrates the statistical analysis of the results
collected from the survey (Farmer and Lewis, 2016).
The researchers noted that over time these variations between the groups decreased, so
there were no notable differences. However, these decreases in magnitude over time can be
explained not only by the differences in smoking topography between the smokers, but also due
to the active comparator group using their preferred cigarettes, resulting in stability of their data.
Upon closer examination, although craving reduction was lower, the category was still higher in
magnitude compared to any of the other categories. If cravings are not reduced by the device,
then it introduces the questions of whether individuals are actually satisfied and whether they
would smoke more due to the lack of reduction in their urge to smoke.
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Table 5: Results from the Modified Cigarette Evaluation Questionnaire during the 91-day US
study comparing users smoking traditional menthol cigarettes or the Phillip Morris S.A. device,
THS 2.2 Menthol (Lewis and Farmer, 2016).

Within the clinical study, smoking topography was characterized by examining puff
volume, puff duration, flow, and puff frequency. During the ambulatory phase, researchers
observed differences in average flow, total number of puffs, puff frequency, and total smoking
time between the two groups. Although users of the THS 2.2 Menthol device had a shorter
smoking time, they had higher total numbers of puff, puff frequency, and average flow. The
value of these differences can be found below in Table 6.
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Table 6: Smoking Topography comparisons in the ambulatory phase of the study (86 days)
comparing smokers using traditional cigarettes of the Phillip Morris S.A device.
Category

Difference

Larger for Individuals using the
THS 2.2. Menthol Device

Average Flow (mL/s)

7.41

x

Number of Puffs

3.34

x

Smoking Duration (min)

1.5

Puff Frequency (puff/min)

2.22

x

Pharmacological Assessment of Nicotine
Pharmacology describes the interactions of drugs within the body. It is commonly broken
in to two areas of study: pharmacodynamics (PD) and pharmacokinetics (PK).
Pharmacodynamics surrounds the response of the body due to the drug, while pharmacokinetics
surrounds the movement of the drug itself (“Pharmacokinetic & Pharmacodynamic Services:
Nuventra.”, n.d.). Nicotine is commonly found in tobacco products, including the THS 2.2
Menthol device. Within the PMTA, Phillip Morris S.A. included data collected from a study
used to research the PK and PD of nicotine from three different products, the heatstick of the
THS 2.2 Menthol device, traditional menthol cigarettes, and nicotine nasal spray (NNS). The 6day study was comprised of healthy individuals between 22 and 65 years old who smoked for at
least 3 consecutive years and smoked at least 10 traditional menthol cigarettes per day (Borders,
n.d.). The study was broken into two periods which each consisted of one day (at least 24 hours)
of nicotine abstinence and 1 day using one of the products. During the study, the participants
interacted with two of the three nicotine products. There were four groups, which differed by the
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sequence of interaction the participants had with the products during the periods. They are as
follows:
-

Group 1: single heatstick of the THS 2.2 Menthol (period 1) | ad libitum use of
traditional menthol cigarette (period 2)

-

Group 2: ad libitum use of the traditional menthol cigarette (period 1) | single heatsick
of the Nasal nicotine Spray (period 2)

-

Group 3: single heatstick of the THS 2.2 Menthol (period 1) | single heatstick of the
one spray per nostril of the Nasal Nicotine Spray (period 2)

-

Group 4: one spray per nostril of the Nasal Nicotine Spray (period 1) | THS 2.2
Menthol (period 2)

Within the experiment, there were two pharmacokinetic comparisons, one between the
THS 2.2 Menthol device & traditional menthol cigarette and another between the nasal nicotine
spray & THS 2.2 Menthol device. The pharmacokinetic comparisons illustrate the relationship
between the concentration of nicotine in the bloodstream (plasma) over time, ranging from 0 to
24 hours. Between the traditional cigarette and the heatstick, the shapes of the PK nicotine
concentration-time curves were similar however, there were lower concentrations of nicotine for
smokers using the heatstick compared to the nicotine cigarettes. Another difference was the time
necessary to reach the maximum nicotine concentration, which was shorter for the heatstick. The
exposure of nicotine, denoted by the area under the nicotine pharmacokinetic curve to the last
quantifiable concentration (AUC 0-last), was lower for the heat stick compared to the traditional
menthol cigarette, 16.5 ng*h/mL and 29.7ng*h/mL, respectively. After completion of the
statistical analyses for both products, researchers noticed large amounts of between-subject

Lara 28
variability, which indicates that the relationship of the nicotine within the plasma differed
between individuals in the study.
Conversely, the next comparison, between the heatstick and the nicotine nasal spray,
showed different results. Specifically, the exposure to nicotine, denoted by AUC 0-last, was
significantly higher for e-cigarettes. The values were 15.6 ng*h/mL and 8.7 ng*h/mL,
respectively. However, researchers still noticed very large values for the between-subject
variability for all of the pharmacokinetic parameters that were analyzed.
Due to its longevity within the body, cotinine, a metabolite of the nicotine, is commonly
used as another method to analyze nicotine exposure (CDC, n.d.b). Another portion of the study
focused on the plasma cotinine levels, beginning after at least 24 hours of smoking abstinence
and before using the nicotine product, which is indicated by To. There were three time points
used in the analysis: To, To+12hr, and To+24hr. Between the two cigarettes, the traditional and
the electronic cigarettes, the concentration of cotinine were similar between 12 hours, however,
after the 24 hours the concentration decreased further than baseline. This ultimately was not was
not significant. The values are indicated below in Table 7.

Table 7: Average plasma cotinine concentrations used to evaluate nicotine exposure within
individuals who smoked using either the THS 2.2 Menthol device or the traditional menthol
cigarettes
THS 2.2 Menthol
Traditional menthol cigarette
device (ng/mL)
(ng/mL)
To
38.0
29.4
To + 12 hr

29.8

33.5

To + 24 hr

20.8

25.7
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The study also looked at the differences between the plasma cotinine concentrations for
individuals using the NNS and the THS 2.2 Menthol device. The same time points were used as
in the previous comparison between the THS 2.2 Menthol device and the traditional menthol
cigarette. As shown in Table 8, there is decline within both of these products over time. There
are differences between the values of the nicotine nasal spray and the Phillip Morris S.A. device,
however, researchers classified these differences as insignificant.

Table 8: Average plasma cotinine concentrations used to evaluate nicotine exposure within
individuals who smoked using either the THS 2.2 Menthol device or the nicotine nasal spray
THS 2.2 Menthol
NNS
device (ng/mL)

(ng/mL)

To

28.2

27.3

To + 12 hr

24.3

21.2

To + 24 hr

17.1

14.2

Aerosol Toxicity
When looking at the toxic effects of the THS 2.2 Menthol device, Phillip Morris S.A.
submitted data from both in vitro and in vivo clinical studies. Within the research, Phillip Morris
S.A. focused on the comparison between the aerosols of the heat stick from THS 2.2 Menthol
device and the smoke created from the 3R4F, a standard reference traditional cigarette created by
the University of Kentucky College of Agriculture (“3R4F”, n.d.).
Before those studies, an initial test was completed to determine the different chemicals
within the aerosols and smoke of the respective products. The screening of the two tobacco
products indicated that there were 80 chemicals in the heatstick aerosol that were in higher
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concentration or non-existent compared to the smoke from the 3R4F reference cigarettes. Most
of these chemicals were either considered Generally recognized as Safe (GRAS) by the FDA (30
chemicals) or used as ingredients to flavor the product (46 chemicals). Although the remaining
ingredients were considered carcinogenic, Phillip Morris S.A, indicated that they didn’t pose a
concern due to their low concentrations, which were below the permissible exposure limits
(PELs) set by Occupation Safety and Health Administration (OSHA). The Center for Tobacco
Products (CTP) did not agree with Phillip Morris S.A.’s interpretation of OSHA standards
because they had no relationship in regard to how the THS 2.2 Menthol device would be used
(FDA, 2019, p. 32). The PELs scope is limited to the workplace, which is not the only
environment where the use of the Phillip Morris S.A. device would be used (FDA, 2019, p. 32).
By using the Organisation for Economic Co-operation and Development’s (OECD’s)
Quantitative Structure-Activity Relationship, Phillip Morris S.A. was able to conduct further
research into toxicity of these chemicals (FDA, 2019, p.32). The technique utilizes the molecular
structures of the chemicals to estimate the potential dangers associated with their chemical
properties. Ultimately, 19 of those original 80 chemicals, most of them being the flavoring
ingredients, were found to be potentially genotoxic or carcinogenic.
Two in vitro tests used in the application were the Neutral Red Uptake (NRU) assay and
Bacterial Reverse Mutation test. The aerosol and smoke of the products can be broken into two
different groups: total particulate matter (TPM) and gas vapor phase (GVP). TPM consists of
particles that can be trapped by a glass-fiber pad, while GVP refers to the particles that pass
through the same pad. The Neutral Red Assay was used to detect viable cells after 24-hr
exposure to culture medium containing the TPM or GPV fractions of the THS aerosol or the
3R4F smoke. This experiment resulted in needing higher concentrations of the aerosol TPM and

Lara 31
GVP compared to the smoke of the 3R4F in order to reach an effective concentration that
reduces the cell population by half (EC50), which indicates that the aerosol was less toxic. The
Bacterial Reverse Mutation Test was used to find chemicals within the TPM fractions of the
aerosol or the smoke causing bacteria to mutate (“Pre-Clinical Assessment Summary”, p. 3). The
experiment found that unlike the reference cigarette, the fractions of the aerosol did not produce
a mutagenic response within the bacteria.
In vivo studies included a 3-month nose-only inhalation rat study and an 18-month
carcinogenicity mouse study. In the first study, the rats were exposed to the smoke, aerosol, or
filtered air, which was used as a control. There was a vast number of biological endpoints that
were examined throughout the study. Overall, most of the endpoints were lower in the aerosol
compared to the smoke. However, interestingly, the prevalence of cell hyperplasia, cell
proliferation that leads to the enlargement of organs (commonly leading to cancer), were similar
in the inhalations of aerosol and smoke. In the 18-month study, the same process was used but in
mice. This was used to identify the risk of cancer. The conclusions from this study indicated that
the was no increase risk to lung cancer for mice exposure to the THS 2.2 aerosol compared to the
control group.

Summary
The research submitted in the PMTA provides evidence for three subject areas that are
important in analyzing the risks of e-cigarettes: Smoking Topography, Assessment of Nicotine,
and Aerosol Toxicity. In regard to smoking topography, the research included in the PMTA
reveals that smoking behavior is different between the two products. Specifically, individuals
using THS 2.2 Menthol device had a higher amount of puff, higher puff frequency, and higher
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average flow rate. From the assessment of nicotine, the research focused on the
pharmacodynamics of nicotine. Comparing the curves of the THS 2.2 Menthol device and the
traditional cigarette, the assessment of nicotine showed that although they both contain nicotine,
individuals using the THS 2.2 Menthol device were exposed to less nicotine. Finally, when
assessing the toxicity of the aerosols from the THS 2.2 Menthol device, the results emphasize the
toxicity of the aerosol. However, when the data is compared to that of the reference cigarette,
3R4F, the results show that the THS 2.2 Menthol toxicities are lower than those created by the
traditional cigarette.
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CHAPTER 5C: COMPARISON BETWEEN THE FINDINGS
From the PMTA, we can see that Phillip Morris S.A. included research from areas
identified by the literature review as being important. Since these areas were covered, the next
step to analyze the regulatory process is to compare the findings from the PMTA to the findings
from the research gathered in the literature review. By comparing the finding, we can show
whether the research within the PMTA was consistent with the ideas of the literature.

Smoking Topography
Although this PMTA evaluates multiple pieces of evidence submitted by Phillip Morris
S.A. to validate the THS 2.2 Menthol device, the conclusions obtained are based on the
comparisons between traditional cigarettes and e-cigarettes. These two devices provide a solution
for the same need; however, the technology of their designs is vastly different. Literature can be
used to provide examples supporting or opposing the claims founded from the data of the
experiments used within the PMTA.
From the literature review, research shows that there is dissimilarity in topography not
only amongst the variation of e-cigarettes but also between traditional and electronic cigarettes.
Like the research from the literature review, the findings of the PMTA also verify that smokers
use traditional cigarettes and e-cigarettes differently. If these devices are used differently, should
they still undergo the same evaluation process? There are many different behavioral aspects that
play a role in analyzing the topography of smokers. Overall, the PMTA concluded that the
smoking topography was different, however, Table 5 provides a closer look into specific
variables within smoking topography. It will be used to illustrate whether the claims are
supported by both the findings from the PMTA and the findings from the literature review.
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Table 5: Variables that can be affected by smoking topography indicated by the findings within
literature.
Findings from Literature
Agree with PTMA findings
Implications
Review
for Consumer
Safety/ Health
E-cigarettes modify smoking
NO. The findings show that puff
HIGH
behavior through having smaller

volume and puff duration were similar.

and longer puffs. (Lee et al.,
2015)
Significant differences were

NO. There were no significant

indicated for puff volume due to

differences in puff volume. The PMTA

the flavor of the e-cigarette.

focused on traditional and e-cigarettes,

(Robinson et al., 2018)

while the research focused only on e-

HIGH

cigarettes.
Nicotine levels change when puff

Did not test.

HIGH

Lower nicotine e-liquids were

Did not test. There was no variation

HIGH

associated with higher puffing

between the amount of nicotine in the

topography (Dawkins et al.,

heatsticks used in the study.

durations are longer. (Farsalinos
et al., 2017)

2016), which can increase
exposure to Harmful and
Potentially Harmful Constituents
(Robinson & Hensel, 2019).
ENDS were significantly higher

YES. The was a difference between

in total volume and inter-puff

total volume between the two products.

interval. (Norton et al. , 2014)

The THS 2.2 Menthol remained higher

HIGH

throughout the study.
Significant differences were

YES. There was a difference between

indicated for puff flow rate due to

the puff flow rate but for the

the flavor of the e-cigarette.

comparison of traditional and e-

(Robinson et al., 2018)

cigarettes.

MEDIUM
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Topography changes can alter many of the processes that occur while smoking. For
example, it can affect the chemicals and particles that are introduced to the user (Robinson and
Hensel, 2019 & Farsalinos et al., 2017). Due to the hazard surrounding some of the chemicals,
the health of the users can be altered due to how they are using the device. Although the
parameters of the experiments within the PMTA do not focus on this relationship, topography
can also be influenced by the strength of the nicotine that is used in the formula of e-liquids, or in
this case the heatstick. Robinson and Hensel (2019) as well as Corocan (2016) found similar
evidence that suggests that the concentration of nicotine can alter the behavior of the smoker.
The support between literature and research completed within PMTA confirm that there are
differences in the topography between smokers. There is, however, dissimilarity between the
implications that this can have in regard to both the system and the user.

Pharmacological Assessment of Nicotine
Due to is addictive properties and reactions inside the body, the exposure of nicotine is
really important, especially when considering the dangers of tobacco from a health perspective.
Within the PMTA, the study focused on the pharmacokinetic factors associated with nicotine.
Table 6 illustrates research that focuses on how nicotine is affected when comparing different
tobacco products. As previously mentioned, the literature shows that there is a difference
between smoking topography between traditional cigarettes and e-cigarettes. However, due to
the differences between findings, the review of literature was inconclusive in determining
whether electronic cigarettes are capable of promoting smoking cessation. Within the PMTA, the
research indicated there was higher nicotine exposure in traditional cigarettes compared to ecigarettes. Just because there is less exposure of nicotine compared to the traditional cigarettes,
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does this mean the device safe? It indicates that there is less harm, but does less harm equate to
more safety of the user?

Table 6: Observation of the effects of smoking on nicotine within the literature.
Findings from Literature
Review

Agree with PTMA findings

Levels of nicotine increased faster NO. The THS 2.2 Menthol device
in the traditional cigarette

reached its maximum nicotine

compared to the cigalike and the

concentration faster than the

tank model e-cigarettes (Rüther et

traditional cigarette

Implications for
Consumer Safety/
Health
HIGH

al., 2018).
The exposure to nicotine is

NO. The PMTA found that they

impacted by the preference of the

were comparable for both the fresh

flavor. (Dempsey et al., 2017)

and menthol flavored heatsticks.

Concentration of nicotine in the

NO. Compared to the concentration

blood plasma increased

of traditional cigarettes, the nicotine

significantly. (Dawkins &

levels from the THS 2.2 Menthol did

Corcoran, 2013)

not increase significantly.

The nicotine plasma

YES. The plasma concentrations

concentrations were higher in

were higher in traditional cigarettes.

HIGH

HIGH

HIGH

traditional cigarettes. (Rüther et
al., 2018)
Urge to smoke decreased, but

NO. Craving reduction reduced, but

after the end of the smoking

it was still less than traditional

period is was not significant. (

cigarettes.

HIGH

Dawkins & Corcoran, 2013)

One thing that was not observed within the literature review was the comparison of ecigarettes to nicotine replacement therapy (NRT). Nicotine nasal spray (NNS) is used to help
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individuals quit smoking by lowering the symptoms associated with withdrawal. This area of the
study indicated significant differences between the nicotine exposure of both the NNS and the ecigarette. Although the research within the PMTA shows the urge to smoke was less when using
the NNS compared to the e-cigarette, the THS 2.2 Menthol system has the ability to expose users
to both higher amounts of nicotine as well as a higher number of Harmful and potentially
harmful constituents (HPHCs). This indicates that if smokers stop using traditional cigarettes,
they would begin using a device that still can expose them to hazardous chemicals. One study
within the PMTA focused on the likelihood of cigarette smokers in switching to electronic
cigarettes (THS 2.2 Menthol). During a 6-week period, around thirty-four percent of individuals
initially began using the e-cigarette, however, within that group only sixteen percent were solely
using the THS 2.2 Menthol device by week 6, and sixteen percent of individual reverted to using
traditional cigarettes prior to week 6.
Similar to the research within the PMTA, Hagedorn et al. (2013) found that the plasma
nicotine levels are higher in traditional cigarettes, however, the findings between these two
conflicts when looking at the time it takes to reach the maximum nicotine plasma concentration.
The research in the PMTA shows a shorter time for individuals using the THS 2.2 Menthol,
while the Hagedorn et al. (2013) indicates the traditional cigarettes were shorter. Differences in
time it takes to reach the maxima could not only have implications in understanding more about
user satisfaction as well as why smokers continue to smoke.

Aerosol Toxicity
Although there is less exposure to nicotine in electronic cigarettes, it does not discount
the other harmful chemicals that are within both types of cigarettes. Within the PMTA, there is
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an abundance of studies that focus on the toxicity of aerosols. Before these compounds and
chemicals can be tested for toxicity, they first have to be identified. Using different methods to
capture particulates from the TPM or the GVP can lead to different results (Eddingsaas et al.,
2018). Within their study, Eddingsaas et al. (2018) found that particles differ depending on the
substance that you are testing, either the aerosol or the e-liquid. They also found differ by the
method you are collecting them, for example, filter pads or methanol impingers have different
efficiencies during collection. The variations between methods and results confirm the need for a
standardized method of identifying chemicals in e-cigarette. The individuals from the Center for
Tobacco Products also suggested their uncertainty about how Phillip Morris S.A.’s collection
method could possibly impact the study.
From the research within Table 7, there are a number of considerations that need to be
made when evaluating electronic cigarettes. During their research, Olmedo et al., (2018) found
that metals can be transferred through the smoking process using e-cigarettes. Although there
was data in the PMTA examining the engineering aspect of the THS 2.2 system, there were no
tests investigating the potential cross-contamination between the metal of the device and product.
Most of the comparisons within the PMTA focused on comparing traditional cigarettes to the
electronic cigarettes, however, due to the differences in technology there are more areas that
should receive testing.
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Table 7: Differences in aerosols findings between research in the literature.
Findings from Literature

Agree with PTMA findings

There are a variety of chemical

YES. The PMTA tested the

reactions that occur through the

ingredients within the heatstick

process of using an e-cigarette.

aerosol.

Implications for
Consumer Safety/ Health
HIGH

(Strongin, 2019)
E-cigarettes have a higher number of

Did not test. The PMTA only

radon decay products, which led to an

tests the toxicity of the

increase in the particle number

ingredients found in the aerosol.

LOW

concentration. (Vargas Trassiera et
al., 2014)
The use E-cigarettes enable metals to

Did not test. The PMTA does

be transferred, exposing the users to

not disclose the particles within

toxic materials. Found that metal

the TPM just the comparison

concentrations were higher in the

between the two products.

HIGH

aerosol than the tank. (Olmedo et al.,
2018)
Some methods provide different

Did not test. The only thing

levels of accuracy in capturing the

altered were the smoking

compounds with the aerosol and the

regimens of the smoking

e-liquids. (Eddingsaas et al., 2018)

machines. PMTA did not

HIGH

disclose what they used to
capture the TPM or the aerosols.
Cell-specific responses were

Did not test. The in vitro studies

dependent on the chemical introduced indicated toxicity but did not
to the cells. Some responses were
more potent than others. (Gerloff et
al., 2017)

show how function was altered.

HIGH
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CHAPTER 5D: QUALITY OF DATA
The studies previously mentioned allow the Center for Tobacco Products to conclude that
these devices are safe for the public. Although most of the evidence support these claims, there
are a number of concerns within the studies that could potentially impact the decision to approve
the device.
This smoking topography study was done in order to determine differences; thus, these
differences could illustrate how smokers really interact with the THS 2.2 Menthol device which
are different from traditional cigarettes. Researchers claimed that these disparities were caused
by the “process of adaptation” for participants using the THS 2.2 Menthol. These devices are
different, so the method or technique of smoking would be modified. However, in order to
counteract these adjustment effects regarding the device properly in the study, researchers could
have either conducted a longer study, provided a more extensive tutorial about the THS 2.2
menthol devices, or given a longer period in the controlled environment to assess whether
participants were using the new device properly.
The design of the pharmacology study of nicotine could have been altered to create a
more compelling argument. The behavioral data collected from the smoking topography study
indicates that there is a difference between the smoking behavior when using the different
tobacco products. As a result, smoking preference could influence the amount of nicotine
introduced in the system of the smokers due to their smoking behavior. Also, the MCEQ in the
behavioral study shows that over the 90 days smokers start altering their opinions of the device.
This introduces whether 5 days is enough for smokers to develop a consist smoking behavior that
reflects how individuals using the new THS 2.2 Menthol device would use the product.
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Overall, the CTP found that it was difficult to assess the long-term exposure using the
data provided from the in vitro and in vivo studies. For example, most data within the in vitro
studies confirmed that the THS 2.2 Menthol device needed higher concentrations to create the
similar toxic effects as the 3R4F. However, the CTP noted that there is no validation behind the
method of generating the aerosols of the heatsticks. For the in vitro studies, the CTP also
indicated concerns about accepting whether the studies provide enough evidence to accurately
predict the carcinogenic potential of aerosol exposure.

Overall
Although most of the categories associated with high health implications were covered
in the PMTA, majority of its findings were not consistent with the research from the literature
review. This section, however, emphasizes the findings that were not covered in the PMTA,
which are also are illustrated in Table 8. Although some of the experiments in Table 8 are not
applicable with research within the PMTA, they are still included because of their implications
regarding consumer safety. For example, Corocan (2016) as well as Robinson & Hensel (2019)
showed that the strength of nicotine impacts smoking behavior. Although the THS 2.2 Menthol
doesn’t use e-liquids, an experiment still could have looked at the how the strength of the
Heatsticks impacts user behavior. One area that was overlooked within the PMTA was the
studies that show the interaction of all the device components. The research conducted by
Olmedo et al. (2018) reveal that users can be exposed to metal components that are inside the
device. This has a huge impact in consumer safety due to the design of e-cigarettes, which use
different metals. Due to their significance, these areas should be incorporated into the PMTA
process so that the entirety of the device is accurately analyzed.
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Table 8: Findings from the literature review that were not covered within the PMTA
Findings from Literature Review

Nicotine levels change when puff durations

Agree with PTMA findings

Implications for
Consumer Safety/
Health

Did not test.

HIGH

Lower nicotine e-liquids were associated

Did not test. There was no

HIGH

with higher puffing topography (Dawkins et

variation between the amount

al., 2016), which can increase exposure to

of nicotine in the heatsticks

Harmful and Potentially Harmful

used in the study.

are longer. (Farsalinos et al., 2017)

Constituents (Robinson & Hensel, 2019).
E-cigarettes have a higher number of radon

Did not test. The PMTA only

decay products, which led to an increase in

tests the toxicity of the

the particle number concentration. (Vargas

ingredients found in the aerosol.

LOW

Trassierra et al., 2014)
The use E-cigarettes enable metals to be

Did not test. The PMTA does

transferred, exposing the users to toxic

not disclose the particles within

materials. Found that metal concentrations

the TPM just the comparison

were higher in the aerosol than the tank.

between the two products.

HIGH

(Olmedo et al., 2018)
Some methods provide different levels of

Did not test. The only thing

accuracy in capturing the compounds with

altered were the smoking

the aerosol and the e-liquids. (Eddingsaas et

regimens of the smoking

al., 2018)

machines. PMTA did not

HIGH

disclose what they used to
capture the TPM or the
aerosols.
Cell-specific responses were dependent on

Did not test. The in vitro studies

the chemical introduced to the cells. Some

indicated toxicity but did not

responses were more potent than others.

show how function was altered.

(Gerloff et al., 2017)

HIGH
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CHAPTER 6: DISCUSSION & CONCLUSION
Within this chapter, I will discuss the implications of the PMTA analysis, summarize the
limitations of research, and provide recommendations for the current evaluation process of ecigarettes.

CHAPTER 6A: IMPLICATIONS OF THE PMTA
The main comparison being made throughout the entirety of the PMTA is between
traditional cigarettes and e-cigarettes. All of the research conducted include the use of traditional
cigarettes to show the differences in the levels of harm between the two products. Throughout
most of the PMTA, the evidence provided depicts the image that electronic cigarettes are less
harmful than traditional cigarettes; however, less harmful does not equate to harmless. These
devices are “less harmful” compared to traditional cigarettes, which have been known to have
detrimental effects. This means that the device is still harmful. If the foundation of this analysis
was based solely on e-cigarettes, rather than a comparison, would the decision of the CTP to
approve this device be the same?
The first research question of this thesis surrounds whether the evidence provided by
companies was substantial. This question was used to examine not only the information that
companies provided, but also the strength of the evidence used to justify the safety of the
electronic cigarette device. The PMTA completed by Phillip Morris incorporated different areas
of research, however under closer observation, the work done does not provide strong enough
arguments to be considered substantial.
Some of the experiments that were selected to build arguments for the safety of the THS
2.2 Menthol device, in particular, were either not verified or did not show conclusive results. As
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previously shown, the Center for Tobacco Products had concerns regarding the in vitro tests,
which were used to show the carcinogenic potential of the aerosol. They also were unsure
whether using the particulate matter or the gas vapor phase impacted the results of the
experiments that were being done. These questions regarding the quality of the experiments
ultimately reduce the efficiency of the regulation process. If companies are able to submit
evidence that doesn’t solidify a strong argument of safety, then the decision by the Center for
Tobacco Products to mark these devices as safe doesn’t rely solely on the science.
One main focus of this regulation is to accurately assess the safety of these devices. If
there are holes in the argument, like the inconclusiveness of results, then how can the FDA
support the idea that these devices are safe. Within the process of regulating these devices, the
FDA can request more information from the companies. However, it seemed as though these
instances of concern or evidence of ambiguity did not warrant the FDA to pursue this route.
From the PMTA, we see Phillip Morris includes multiple studies to justify the safety of
the THS 2.2 Menthol device. Although there is an abundance of evidence provided, there are still
questions surrounding the quality of the experiments they chose to include. The FDA has the
final decision in approving these devices, but they have to determine whether the evidence
provided is satisfactory in showing safety. Despite approving these devices, the FDA was not
able to accurately assess the THS 2.2 Menthol device due to the limitations of the research that
was provided.
The second research question addresses whether the regulation process is effective for
analyzing e-cigarette devices. Despite the inclusion of important research areas in the PMTA,
more research needs to be done in order to effectively analyze e-cigarette devices. The emphasis
of traditional cigarettes within the PMTA eliminated the need for research that placed attention
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on simply e-cigarettes. For example, the in vitro studies focused only on the toxicity of the
aerosols in relation to genetics, however, there was no research that indicated whether the use of
this device generates functional changes in the cells. The lungs are an important part of
respiratory system, particularly for its blood-air interface, which regulate gas exchange within
the body. The barrier associated with the cells of the lungs have the ability to filter particles,
restricting them from entering the bloodstream. Since the route of transmission affects the
respiratory system, research that shows how the aerosols affect cellular structures should be
important in the assessment of the e-cigarettes.
Also, the representation of potential users was limited within all of the clinical studies.
Phillip Morris S.A. claimed that the THS 2.2 Menthol device was only aimed at current and
former smokers, but the studies focused solely on current smokers. Groups of individuals, like
former smokers, non-smokers and youth, were not included. Phillip Morris S.A. used data from a
likelihood of use study to verify the potential types of users that would interact with their
product. From the study, Phillip Morris S.A. concluded that these groups were not going to be
using their products. However, McKenley et al. (2018) found that Phillip Morris’s data was
unsuccessful in confirming that youth, specifically, would neither find their products alluring nor
start using them [20]. From the current increase use of e-cigarettes by the youth, the results from
Phillip Morris seem likelihood of use study seem unlikely.
Within their application, Phillip Morris S.A indicated that the FDA did not expect youth
representation within the studies. However, like most of their research in the PMTA, which
focused on the comparison between cigarette products, Phillip Morris S.A. could have included
information about the youth interactions with any of their other products for a comparison but
did not (p.76). By limiting the research to individuals who are current smokers, we are unaware
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of the effects that could happen for individuals who do not smoke but would consider using ecigarettes.
Finally, many of the conclusions from the studies included within the PMTA were not
supported by the research from the literature, which had high implication for the health of the
consumer. Some elements were not even examined within the PMTA. There are a multitude of
differences between traditional cigarettes and e-cigarettes, especially when considering
technology. The system of Phillip Morris is more complex than a traditional cigarette, yet no
research looked at whether the heating elements of the system interacted with the user. Since
they were not addressed, it is difficult to say that this process is effective because not all of the
health implications are considered when analyzing e-cigarettes.
The effectiveness of the regulation process for e-cigarettes is limited by the
process that is currently in place to evaluate its predecessor, the traditional cigarette. To be
effective, the process for regulating e-cigarettes cannot rely solely on the research that is required
for traditional cigarettes. The research needs to include information that focuses on the
technological differences that makes these devices, e-cigarettes, more complex than traditional
cigarettes. The regulation process was effective due the inclusion of important research areas
required in analyzing these devices, however, in order to make an accurate evaluation of these ecigarette devices, more focus needs to be placed on the e-cigarettes rather than the comparison
between the traditional cigarettes and electronic cigarettes.
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CHAPTER 6C: LIMITATIONS OF RESEARCH
The biggest limitation of the research conducted in this thesis is the access to PMTAs.
There was only one application for e-cigarettes available on the FDA website. In order to
effectively assess the evaluation process of these devices, more applications should be used to
develop a more comprehensive understanding of the research being provided by companies.
More applications would affirm whether companies are relying specifically on traditional
cigarettes to develop conclusions about their devices. By only using the Phillip Morris’
application, I am limited to a single process for one type of e-cigarette device.
While the heatsticks of Phillip Morris’ device do contain propylene glycol, a humectant
found in e-liquids, many of the e-cigarettes marketed have a variety of flavors and formulas that
contain a larger number of liquid components, which would certainly impact the research that is
required. When heated, the e-liquid undergoes a phase change, going from liquid to vapor. Thus,
companies would need to determine whether the vapors return to liquid when exposed to the
temperature of the body. They would also have to show how these particles interact with the
body in both the vapor and liquid form. Within the Phillip Morris application, there were three
heatstick: Marlboro, smooth menthol and fresh menthol. The research for each heatstick was
done separately, however, to make a direct comparison of the two the experiments should have
been conducted together. The conclusion was that the flavor had no impact on the study,
however, that is contradictory to a recurring idea within the literature.
The research in this thesis was further limited by the redactions within the PMTA
application. Sections containing information about the engineering of device were marked,
limiting my ability to examine evidence concerning the device. This could potentially impact my
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analysis, because it restricts the information that can be used to justify the safety of the THS 2.2
Menthol device.

CHAPTER 5C: RECOMMENDATIONS
Overall, the process for the evaluation of e-cigarettes is very broad. The companies are
responsible for providing information they deem relevant. Thus, there is no standard for what
research is required. Within the PMTA, there was hesitancy by the Center for Tobacco Products
to accept some of the experimental research that was included. There was also uncertainty
regarding whether the methods for sample collection within the experiments would impact the
results of studies. Although companies are responsible for providing research, the CTP should
develop acceptable tests or at least guidelines for what needs to be shown, especially in the areas
of research.
One part of the process that should be altered is the labeling and the determination of
potential users. The data from Phillip Morris indicated that youth interactions with this device
were low. However, an overwhelming number of youths have become e-cigarette users. The
FDA should require marketing research where either companies or the FDA host a meeting with
a variety of individuals to see the prevalent opinions being made about the device for all groups,
including children. This would help discover potential users and help companies learn what
characteristics of their products need to be altered to lower their appeal to youth. In addition to
the likelihood of use study, Phillip Morris relied on areas where their device was already
marketed to help affirm the notion that the likelihood of youth use would be lower. Although the
evidence could be persuading, these places, like Japan, have different cultures than the United
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States; thus, they cannot be used to accurately model or predict what would happen in the United
States.
Another recommendation would be to increase the availability and accessibility of
information for PMTAs. Transparency not only allows the government to be accountable, but
also allows the public to understand processes that are in place to protect them. Lack of
transparency can impact the relationship between the public and government, creating mistrust
and restlessness towards the government. The inability to gather information about PMTAs
impacts the analysis of this thesis. It limits not only what I was able to find, but also what I was
conclude. The inability to gather information also impacts the information being reported on the
FDA website. When looking into the different pathways of process, there were tables responsible
for tracking the frequency of pathways used by companies, however, these tables were unable to
depict the breakdown of the type of product. This emphasizes the need for more information
because how would individuals know whether type of product a company makes impacts the
pathway it would use. This would be helpful in showing whether e-cigarettes or traditional
cigarette companies favor one pathway over the others.
In order to increase transparency, there should be more information available for
monitoring the regulation process. One way to accomplish this would be to create a database that
includes e-cigarette products involved with the regulation process. This would be helpful in
illustrating whether companies are approved and whether they are in the process of approval
allowing individuals to know more about the products they are using.
In addition to the accessibility of information, the process of enforcing the regulation for
e-cigarettes needs to be improved. A multitude of e-cigarette products did not undergo the
regulation process, yet they were still being sold on the market. By allowing these products to be
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marketed without approval, the FDA allowed companies to bypass the regulation process and to
introduce potentially harmful products onto the market. This means that e-cigarette companies
were not held accountable for the products that they were producing for consumers.
In July of 2019, the courts mandated the FDA to issue a deadline for marketed e-cigarette
products that would require companies to submit a PMTA by May 12, 2020. Due to the COVID19 pandemic, this deadline for the PMTAs was further postponed until September. This mandate,
however, does not provide an optimal solution because companies are still able to market their
device up to one year while their applications are under review by the FDA. Ultimately, this
allows the public to still interact with devices that have not been deemed safe for consumer use.
In order to decrease the threat of these devices, e-cigarettes that have not received a marketing
order should be taken off the market, especially if they were placed on the market after the FDA
received the power to regulate electronic cigarettes. If companies are allowed to continue
marketing their devices, the system created to regulate these devices would be contradicted.
These devices were not supposed to be marketed until receiving a market order from the FDA,
which did not occur. Thus, allowing e-cigarette devices to stay on the market decreases the
enforcement of the regulation process.
Another area that should be focused on is the flavoring of e-liquids, which is the greatest
obstacle against deterring youth from e-cigarettes. There are a multitude of flavors, like candy,
that entice children to use these products. Flavors have been associated with the perception of
less risk; thus, more needs to be done in order to provide a solution. Prior to the federal flavoring
ban, states and local governments were enacting flavor bans to protect their constituents against
the products. These actions helped initiate the federal ban on that went into effect in February
2020. This is probably the most effective way to prevent children from using e-cigarettes,
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however, there are children who have already become consistent users. In order to show the
children who already have been affected the risks, more research needs to be done to determine
the mechanisms that make these devices dangerous so that the public can be aware of the all the
risks associated with using e-cigarettes. Also, the information can be used in the current
campaigns that are used to dissuade youth from using these products.
Although these devices are not used for medical purposes, the design of e-cigarettes are
similar to the medical devices that deliver substances to individuals. Due to the complexities of
its design, e-cigarettes seem more comparable to medical devices than traditional cigarettes. Ecigarettes are regulated the same as cigarettes because they include nicotine, however, most of
the tobacco products under this regulation have simplistic designs. The evaluation of these
process does not account for the intricacies associated with technology within the systems of ecigarettes. The research has to account for more than what is provided for traditional cigarette,
which is the limitation of the research included in the PMTA. In order to improve the process,
more research needs to be done to understand interactions of the devices within all levels of the
system.
The improvement of the PMTA surrounds increasing the validity and quality of research.
The broadness of the current process gives too much control to the companies, which allow them
to pick and choose what evidence they provide. By requiring guidelines around research, the
FDA can strengthen its expertise while holding companies more accountable for what they
include in their PMTA. Another way to improve the process is to implement some of
characteristics of the process for the regulation of Class II and Class III medical devices, which
undergo a high level of scrutiny by the Center for Devices and Radiological Health. This can

Lara 52
allow insight from technical expertise, which focuses on the entire system rather focusing on the
delivery of the nicotine.
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